Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New shot in the arm for cancer treatment?

NCT ID NCT04606381

Summary

This early-stage study is testing a new way to give the cancer drug amivantamab—as an injection under the skin instead of through an IV. It aims to find a safe and effective dose for this injection method in people with advanced solid tumors that have not responded to other treatments. The main goals are to check for side effects and see how the drug moves through the body.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NEOPLASMS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Cedars Sinai Medical Center

    West Hollywood, California, 90048, United States

  • Chungbuk National University Hospital

    Cheongju-si, 28644, South Korea

  • Community Health Network

    Indianapolis, Indiana, 46256, United States

  • Langone Health at NYC University, NYU School of Medicine

    New York, New York, 10016, United States

  • Providence Portland Medical Center

    Portland, Oregon, 97213, United States

  • Royal Marsden Hospital

    Sutton, SM2 5PT, United Kingdom

  • Samsung Medical Center

    Seoul, 06351, South Korea

  • Sarah Cannon Research Institute

    Nashville, Tennessee, 37203, United States

  • Seoul National University Bundang Hospital

    Seongnam-si, 13620, South Korea

  • Severance Hospital Yonsei University Health System

    Seoul, 03722, South Korea

  • The Christie Nhs Foundation Trust

    Manchester, M20 4BX, United Kingdom

  • University Health Network

    Toronto, Ontario, M5G 2M9, Canada

Conditions

Explore the condition pages connected to this study.